ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

Hawaiian Have Highest Cancer Rate In U.S.

April 29, 1983

Hope for FDA authority over tobacco products dies in Congress.

October 15, 2004

Ethics Advisory Board to Consider Compensation Issue

September 7, 1979

Breast Cancer Coalition Widens Its Agenda For Advocacy, Vows To Fight NIH Cutbacks

May 5, 1995

Crizotinib Eliminated Tumors In 7 of 8 Children with ALCL

May 25, 2012

NCI To Pay 34 Percent Of Grants, At 155 Payline; $100 Million for Centers to Fund All Core Grants

January 29, 1988